Biography
Dr. Marlies Sproll joined MorphoSys in October 2000 as R&D department head. In November 2005, Dr. Sproll was promoted to Chief Scientific Officer, leading MorphoSys’s departments of research and development as well as alliance management.
Before joining MorphoSys, Dr. Sproll worked for seven years at the Vienna research facility of Boehringer Ingelheim. After initially being employed as laboratory head, she later took over international project management for several development projects of therapeutic antibodies as well as antibody conjugates and vaccines in the field of oncology. From 1988 to 1993, Dr. Sproll was lab leader at Merck KGaA in Darmstadt, Germany, where she was involved in the preclinical development of therapeutic antibodies.
Dr. Sproll has a Ph.D. from the Max Planck Institute in Tübingen, Germany, and was awarded a Doctor of Natural Science by the University of Stuttgart, Germany. Subsequently, she held research positions as a post-doctoral fellow at the Friedrich-Miescher-Laboratory of the Max-Planck-Institute in Tübingen, Germany.